DividendMapper
MetLife, Inc. logo

MET

MetLife, Inc.

  • Financial
  • US companies in Insurance - Life (11)
  • NYSE · USD
  • Mkt cap $63.5bn

$99.98

as of 27 Oct 2026, 4% below its 52-week high

Screens as well placed to keep growing its dividend, with low cut-risk signals. Its valuation looks somewhat extended against its own history.

These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.

Trailing yield
2.32%Last 12 months of regular payments at today's price
Forward yield
2.42%Each payment expected in the next 12 months, not the latest one doubled
Cash cover
11.0×Free cash flow over dividends paid
Earnings cover
2.2×Insurers and banks set dividends from capital generation, so their accounting earnings can sit well below the payout.
5y dividend growth
+4.3% a yearNo cut since FY2002
Next ex-dividend date
Declared3 Nov 2026Quarterly dividend of $0.59

Compared with US companies in Insurance - Life (11)

  • Trailing yield is higher than 6 of the 10 other US companies in Insurance - Life.
  • 5y dividend growth (as paid) is lower than 6 of the 8 other US companies in Insurance - Life with a 5y growth figure.

Quality

83

High

Capacity to keep growing the dividend

Risk

25

Low

Signals of dividend-cut pressure

Trim

57

Moderate

How extended the valuation looks

Why Trim is 57

MET against US companies in Insurance - Life (11)

Valuation against its own history

As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of MET’s past readings.

  • P/E15.2×P77, poor for this measure
  • Yield2.71%P8, poor for this measure
  • FCF payout10.1%P6, good for this measure
  • DGR 5y+4.3%P3, poor for this measure
  • ROIC0.8%P22, poor for this measure

Net debt / EBITDA is left out: for banks and insurers, debt is part of the business, so the ratio says little.

Open valuation history

Forecast your income with the MET dividend calculator

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.